In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-17 of 17 for your search:
Drug:  omega-3 fatty acid
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EA1/174/05, NCT00168987
2.

Phase: Phase IV
Type: Supportive care
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: 123omega, VN2005/35, NCT00488904
3.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-989255, CAN-NCIC-SC18, NCI-P02-0205, NCT00031707, SC18
4.

Phase: Phase II, Phase I
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CLB-9473, NCI-P97-0097, CALGB-9473, NCT00003077
5.

Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 to 90
Sponsor: NCCAM
Protocol IDs: P50 AT000437, JHM - IRB # 03-02-10-12, NCT00094562
6.

Phase: Phase II
Type: Supportive care
Status: Temporarily closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2007DR2232, 1345 (institution), 120/07 (ethics review board), NCT00533078
7.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Over 21
Sponsor: NCI, Other
Protocol IDs: CDR0000581419, P30CA069533, OHSU-3872, OHSU-CTRC-1037, 3872, NCT00627276
8.

Phase: Phase I
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: NEDH-91062786, NCI-P92-0019
9.

Phase: No phase specified
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: UCLA-HSPC-9508339, NCI-V96-0940
10.

Phase: No phase specified
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CSMC-00006359, CSMC-00000509, NCT00114296
11.

Phase: No phase specified
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000443617, P30CA069533, OHSU-CI-CPC-04131-LX, VAMC-04-0303/ M1016, DOD-W81XWH-04-1-0296, OHSU-1117, KPNW-NW-05SLIEB-01, VAMC-04-0303, DOD-A-12538, OHSU-KPNW-NW-05SLIEB-01, NCT00253643
12.

Phase: No phase specified
Type: Prevention
Status: Completed
Age: 18 to 80
Sponsor: Other
Protocol IDs: IFR02/2004, NCT00145015
13.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: CDR0000505501, UCSF-03553, UCSF-H5664-22834-04A, NCT00402285
14.

Phase: No phase specified
Type: Behavioral study, Biomarker/Laboratory analysis
Status: Closed
Age: 40 to 75
Sponsor: NCI, Other
Protocol IDs: 01-07-026, P50 CA 92131-01A1, NCT00798876
15.

Phase: No phase specified
Type: Treatment
Status: Closed
Age: 40 to 75
Sponsor: NCI, Other
Protocol IDs: 01-07-026-21, P50CA092131-01A1, NCT00836615
16.

Phase: No phase specified
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: AICR 08-0131, UKCRN 6873, NCT01032343
17.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 19 and over
Sponsor: Other
Protocol IDs: 20.179/2010-0, NCT01575340
New Search